copri can cause insulin resistance, exacerbate glucose intolerance, and increase mouse circulating BCAA levels (254, 256)
In particular, -chlorothioacetamide probe 21 labels a much higher number of proteins compared to its chloroacetamide analog ( 19 , Fig
5 Therapeutic advances in overcoming resistance in HGSOC In recent years, treatment strategies for overcoming HGSOC drug resistance have continuously advanced, encompassing multiple aspects, including combination chemotherapy, targeted therapy, personalized treatment, immunotherapy, and emerging epigenetic and oncolytic virus therapies
As a result, technological advances in microbiome profiling, such as metagenomic analyses and 16S ribosomal RNA sequencing, have facilitated the detailed characterization of microbial communities in CKD patients